These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Serum beta 2-microglobulin and human immunodeficiency virus infection. Lacey JN; Forbes MA; Waugh MA; Cooper EH; Hambling MH AIDS; 1987 Jul; 1(2):123-7. PubMed ID: 3130078 [TBL] [Abstract][Full Text] [Related]
5. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II. AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101 [TBL] [Abstract][Full Text] [Related]
6. [Increase of beta 2-microglobulin in drug addicts with anti-HIV antibodies and high risk of AIDS]. D'Angelo G; Giardini C; Zanco MD; Calvano D; Crovetti G; De Filippo C Minerva Med; 1991; 82(1-2):45-8. PubMed ID: 2000173 [TBL] [Abstract][Full Text] [Related]
7. [Immunoglobulin A and human immunodeficiency virus type 1 infection in parenteral drug abuse addicts]. Muga R; Tor J; Solsona L; Villanueva C; Pol M; Jacas C; Sabriá M; Rey-Joly C; Foz M Med Clin (Barc); 1991 Mar; 96(10):361-3. PubMed ID: 2046411 [TBL] [Abstract][Full Text] [Related]
8. Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection. Chironna M; Fanelli M; Potenza D; Serio G; Quarto M Int J Clin Lab Res; 1994; 24(2):90-3. PubMed ID: 7919434 [TBL] [Abstract][Full Text] [Related]
9. Serum B2-microglobulin and human immunodeficiency virus infection in intravenous drug users: a cross-sectional study. De Mercato R; Rezza G; Giuliani M; Perna E; Iovinella V; Bassi A; Tagliaferro R Boll Ist Sieroter Milan; 1990 Jun; 69(2):447-8. PubMed ID: 2152304 [TBL] [Abstract][Full Text] [Related]
10. [Immunoglobulins, beta-2 microglobulin and lymphocyte subpopulations in patients addicted to parenteral drugs (IVDA)]. Ramos V; Castro MA; de la Iglesia F; Martínez MM; Juega J; Sánchez P; Barbuzano C; Pedreira JD An Med Interna; 1992 Nov; 9(11):538-42. PubMed ID: 1467401 [TBL] [Abstract][Full Text] [Related]
11. [Occurrence of HTLV-III infection and related clinical forms in a homogeneous group of drug addicts. Significance of immunologic changes and evaluation of risk factors]. Tassinari MC; Gualandi M; Guerra G; Barbieri D; Benassi N; Lazzarato M; Dallara G; Gallerani M Recenti Prog Med; 1986 Oct; 77(10):461-5. PubMed ID: 3547522 [No Abstract] [Full Text] [Related]
12. The prevalence of AIDS, AIDS related complex and HIV seropositivity in a large population of patients with congenital clotting disorders. Girolami A; Luzzatto G; Dal Bo Zanon R; Lazzaro AR; De Rossi A; Stocco D Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):825-32. PubMed ID: 2467853 [TBL] [Abstract][Full Text] [Related]
13. [Immunological and cytochemical changes in groups at risk for acquired immunodeficiency syndrome and in symptomatic and asymptomatic carriers of antibodies to human immunodeficiency virus. A multivariate study]. Gutiérrez Martín M; Romero Colás MS; Callén Sevilla L; Lasierra Díaz P; Larrad Mur L Med Clin (Barc); 1987 Oct; 89(13):544-8. PubMed ID: 3320599 [No Abstract] [Full Text] [Related]
14. [Chemotaxis deficiency in patients with HIV infection]. Ciaffoni S; Roata C; Turrini A; Gandini A; Crocco I; Mazzi R; Malena M; Luzzati R; Aprili G Boll Ist Sieroter Milan; 1991-1992; 70(1-2):433-7. PubMed ID: 1670045 [TBL] [Abstract][Full Text] [Related]
15. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I. AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100 [TBL] [Abstract][Full Text] [Related]
16. High beta2 microglobulin serum levels in human immunodeficiency virus infected intravenous drug addicts. Caruso L; Trischitta C; Russello M; Bertino G; Onorante A; Rapisarda S; Patania S; Tropeano L J Chemother; 1989 Jul; 1(4 Suppl):1077-8. PubMed ID: 16312778 [No Abstract] [Full Text] [Related]
17. Elevated serum beta-2-microglobulin--a prognostic marker for development of AIDS among patients with persistent generalized lymphadenopathy. Morfeldt-Månson J; Julander I; von Stedingk LV; Wasserman J; Nilsson B Infection; 1988; 16(2):109-10. PubMed ID: 3286507 [TBL] [Abstract][Full Text] [Related]
18. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS]. Halota W; Jaruga B; Pawłowska M Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343 [TBL] [Abstract][Full Text] [Related]
19. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection]. Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488 [TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Lee RM; Branch DW; Silver RM Am J Obstet Gynecol; 2001 Sep; 185(3):748-53. PubMed ID: 11568809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]